Are you over 18 and want to see adult content?
More Annotations
A complete backup of higieneyseguridadlaboralcvs.wordpress.com
Are you over 18 and want to see adult content?
A complete backup of wimbledoncollege.org.uk
Are you over 18 and want to see adult content?
A complete backup of camarillochurchofchrist.com
Are you over 18 and want to see adult content?
A complete backup of lindigdesigns.com
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of ikedamohando.co.jp
Are you over 18 and want to see adult content?
A complete backup of actualitesdroitbelge.be
Are you over 18 and want to see adult content?
A complete backup of madaracosmetics.com
Are you over 18 and want to see adult content?
A complete backup of underourskin.com
Are you over 18 and want to see adult content?
Text
PUBLICATIONS
Real-world survival of men with metastatic hormone-sensitive prostate cancer treated with abiraterone acetate or docetaxel and comparison with clinical trial outcomes →. Geynisman, DM, Correa, AF, Ramamurthy, C, Beck, JR, Handorf, E. February 2021. Abstract. CAREERS | FLATIRON HEALTH A career at Flatiron is a chance to work with everyone involved in the future of cancer — all under one roof. Researchers, academics, oncologists, engineers and more all work together here to deliver better solutions. This means we have a chance to impact more lives and deliver better outcomes for patients. See open positions. OUR TEAM | FLATIRON HEALTH Flatiron is a team of passionate, curious individuals from a wide range of backgrounds, dedicated to improving cancer treatment and accelerating research. FOR COMMUNITY ONCOLOGY OncoEMR® enhances your ability to bring precision medicine to your patient care. OncoTrials® identifies eligible patients so you can help them get access to clinical trials. Flatiron HC™ has been ranked the #1 end-to-end oncology technology solution by Black Book Research. OncoEMR ® is top-rated for overall satisfaction by KLAS’2019
REAL-WORLD EVIDENCE: DATA QUALITY, USE CASES & MORE Real-world data can evaluate clinical outcomes of patients who were excluded in trials due to organ dysfunction, which enhances our safety data, and can lead to label expansion. Real-world data makes it possible to evaluate treatment outcomes of patients that were initially excluded in clinical trials. FLATIRON HEALTH ANNOUNCES CLINICAL DECISION SUPPORT Flatiron Health, a healthcare technology company focused on accelerating cancer research and improving patient care, announces the availability of its clinical decision support and pathways application, Flatiron Assistâ„¢, in the App Orchard. Flatiron Assistâ„¢ supports oncologists in selecting therapies in line with best clinical practices, including the National Comprehensive CancerNetwork
REAL-WORLD DATA DEFINITIONS: RWD, RWE, ENDPOINTS & MORE Real-world endpoints are precisely defined variables intended to reflect outcomes of interest that are statistically analyzed to address a particular research question. (Examples include: real-world overall survival (rwOS); real-world progression-free survival (rwPFS); and rwRR (real-world response rate)) Variants: Real-World Outcomes.LOG IN USING
OncoEMR Help Center Customer Secure Login Page. Login to your OncoEMR Help Center Customer Account. RESEARCHX | REAL-WORLD EVIDENCE WEBINARS ON USE CASES 11:00am – 12:00pm ET. Live Q&A. Real-world evidence generated from the EHR has been shown to be more relevant, timely, and representative for health technology appraisals (HTA) decision-making compared to evidence from clinical trials. In this session, use cases demonstrating the value of using RWE in the HTA setting will beshowcased as well
FLATIRON HEALTHFOR COMMUNITY ONCOLOGYFOR LIFE SCIENCESFOR ACADEMICS & HOSPITALSONCOEMRONCOBILLING Flatiron Health. Dr. James Hamrick & Sarika Vora in their weekly team stand-up. Cancer is smart. Together, we can. be smarter. Accelerating cancer research and improving the quality of care requires the entire industry to work together. Our products connect community oncologists, academics, hospitals, life science researchers and regulators onPUBLICATIONS
Real-world survival of men with metastatic hormone-sensitive prostate cancer treated with abiraterone acetate or docetaxel and comparison with clinical trial outcomes →. Geynisman, DM, Correa, AF, Ramamurthy, C, Beck, JR, Handorf, E. February 2021. Abstract. CAREERS | FLATIRON HEALTH A career at Flatiron is a chance to work with everyone involved in the future of cancer — all under one roof. Researchers, academics, oncologists, engineers and more all work together here to deliver better solutions. This means we have a chance to impact more lives and deliver better outcomes for patients. See open positions. OUR TEAM | FLATIRON HEALTH Flatiron is a team of passionate, curious individuals from a wide range of backgrounds, dedicated to improving cancer treatment and accelerating research. FOR COMMUNITY ONCOLOGY OncoEMR® enhances your ability to bring precision medicine to your patient care. OncoTrials® identifies eligible patients so you can help them get access to clinical trials. Flatiron HC™ has been ranked the #1 end-to-end oncology technology solution by Black Book Research. OncoEMR ® is top-rated for overall satisfaction by KLAS’2019
REAL-WORLD EVIDENCE: DATA QUALITY, USE CASES & MORE Real-world data can evaluate clinical outcomes of patients who were excluded in trials due to organ dysfunction, which enhances our safety data, and can lead to label expansion. Real-world data makes it possible to evaluate treatment outcomes of patients that were initially excluded in clinical trials. FLATIRON HEALTH ANNOUNCES CLINICAL DECISION SUPPORT Flatiron Health, a healthcare technology company focused on accelerating cancer research and improving patient care, announces the availability of its clinical decision support and pathways application, Flatiron Assistâ„¢, in the App Orchard. Flatiron Assistâ„¢ supports oncologists in selecting therapies in line with best clinical practices, including the National Comprehensive CancerNetwork
REAL-WORLD DATA DEFINITIONS: RWD, RWE, ENDPOINTS & MORE Real-world endpoints are precisely defined variables intended to reflect outcomes of interest that are statistically analyzed to address a particular research question. (Examples include: real-world overall survival (rwOS); real-world progression-free survival (rwPFS); and rwRR (real-world response rate)) Variants: Real-World Outcomes.LOG IN USING
OncoEMR Help Center Customer Secure Login Page. Login to your OncoEMR Help Center Customer Account. RESEARCHX | REAL-WORLD EVIDENCE WEBINARS ON USE CASES 11:00am – 12:00pm ET. Live Q&A. Real-world evidence generated from the EHR has been shown to be more relevant, timely, and representative for health technology appraisals (HTA) decision-making compared to evidence from clinical trials. In this session, use cases demonstrating the value of using RWE in the HTA setting will beshowcased as well
PUBLICATIONS
Real-world survival of men with metastatic hormone-sensitive prostate cancer treated with abiraterone acetate or docetaxel and comparison with clinical trial outcomes →. Geynisman, DM, Correa, AF, Ramamurthy, C, Beck, JR, Handorf, E. February 2021. Abstract. ABOUT US | FLATIRON HEALTH Our Story. Flatiron Health has come a long way since 2012, when entrepreneurs Nat Turner and Zach Weinberg saw firsthand how a fragmented and siloed healthcare system impacted a family member’s cancer treatment, and set out to gather the best minds in medicine and technology to transform the way cancer is understood and treated. Today, Flatiron continues to lead in U.S. oncology real-world FOR COMMUNITY ONCOLOGY OncoEMR® enhances your ability to bring precision medicine to your patient care. OncoTrials® identifies eligible patients so you can help them get access to clinical trials. Flatiron HC™ has been ranked the #1 end-to-end oncology technology solution by Black Book Research. OncoEMR ® is top-rated for overall satisfaction by KLAS’2019
ROCHE TO ACQUIRE FLATIRON HEALTH TO ACCELERATE INDUSTRY Acquisition will bring together two companies committed to improving the lives of cancer patients through the evolving field of healthcare data and analytics The companies will leverage their combined expertise to advance the use of real-world evidence to set new industry standards for oncology research and development Flatiron Health to continue its operations as a FLATIRON PLATFORM: LOGIN TO YOUR ACCOUNT © 2013-2021 Flatiron Health, Inc. All rights reserved. Privacy Policy | Acceptable Use PolicyOCM MEASURE LIST
OCM MEASURE LIST Version 1.6 . Effective January 1, 2020 . Prepared by: RTI International . 3040 E. Cornwallis Road . Research TrianglePark, NC 27709
REAL-WORLD EVIDENCE RESEARCH AT ASCO20: HIGHLIGHTS Collectively, Flatiron’s presentations at this year’s American Society of Clinical Oncology Annual Meeting (ASCO20) display the broad impact of EHR-derived real-world evidence (RWE) across the oncology therapeutic lifecycle: from discovery through development and, ultimately, in support of patient care. REGULATORY PERSPECTIVE ON REAL-WORLD ENDPOINTS WITH SEAN Sean Khozin, formerly of the FDA’s Oncology Center of Excellence, discusses the challenges as well as the progress in generating reliable endpoints from real-world datasets at the 2018 Flatiron Research Summit. Of note, Dr. Khozin proposed a framework for contextualizing the many endpoints available to researchers working with real-world data. AN INTRO TO REAL-WORLD ENDPOINTS IN ONCOLOGY One key thing to keep in mind when comparing real-world endpoints with trial endpoints is, in the real world, patients come in to see the physician when they don't feel well. Relative to trials, there's this very specific cadence and expectation that we will REAL-WORLD DATA AND THE CASE OF THE MISSING DEATHS Where to look for missing deaths. The risks of performing naive outcome analyses on EHR-derived real-world data are not to be underestimated. If you depend on accurate real-world overall survival (rwOS) estimates this is something you need to pay attention to: real-world data (RWD) companies must address the issue of low mortality sensitivity in order for the data to be considered fit FLATIRON HEALTHFOR COMMUNITY ONCOLOGYFOR LIFE SCIENCESFOR ACADEMICS & HOSPITALSONCOEMRONCOBILLING Flatiron Health. Dr. James Hamrick & Sarika Vora in their weekly team stand-up. Cancer is smart. Together, we can. be smarter. Accelerating cancer research and improving the quality of care requires the entire industry to work together. Our products connect community oncologists, academics, hospitals, life science researchers and regulators on ABOUT US | FLATIRON HEALTH Our Story. Flatiron Health has come a long way since 2012, when entrepreneurs Nat Turner and Zach Weinberg saw firsthand how a fragmented and siloed healthcare system impacted a family member’s cancer treatment, and set out to gather the best minds in medicine and technology to transform the way cancer is understood and treated. Today, Flatiron continues to lead in U.S. oncology real-worldPUBLICATIONS
Real-world survival of men with metastatic hormone-sensitive prostate cancer treated with abiraterone acetate or docetaxel and comparison with clinical trial outcomes →. Geynisman, DM, Correa, AF, Ramamurthy, C, Beck, JR, Handorf, E. February 2021. Abstract. CAREERS | FLATIRON HEALTH A career at Flatiron is a chance to work with everyone involved in the future of cancer — all under one roof. Researchers, academics, oncologists, engineers and more all work together here to deliver better solutions. This means we have a chance to impact more lives and deliver better outcomes for patients. See open positions.FLATIRON ASSIST™
Flatiron Assist™ captures key data points to speed up prior authorizations and surfaces insights to help practices achieve success in value-based arrangements. The nice thing about Flatiron Assist is that you can get right where you want to go—and get there quickly—without having to dig through an algorithm. OUR TEAM | FLATIRON HEALTH Flatiron is a team of passionate, curious individuals from a wide range of backgrounds, dedicated to improving cancer treatment and accelerating research. FLATIRON HEALTHFOR COMMUNITY ONCOLOGYFOR LIFE SCIENCESFOR ACADEMICS & HOSPITALSONCOEMRONCOBILLING Flatiron Health. Dr. James Hamrick & Sarika Vora in their weekly team stand-up. Cancer is smart. Together, we can. be smarter. Accelerating cancer research and improving the quality of care requires the entire industry to work together. Our products connect community oncologists, academics, hospitals, life science researchers and regulators on ABOUT US | FLATIRON HEALTH Our Story. Flatiron Health has come a long way since 2012, when entrepreneurs Nat Turner and Zach Weinberg saw firsthand how a fragmented and siloed healthcare system impacted a family member’s cancer treatment, and set out to gather the best minds in medicine and technology to transform the way cancer is understood and treated. Today, Flatiron continues to lead in U.S. oncology real-worldPUBLICATIONS
Real-world survival of men with metastatic hormone-sensitive prostate cancer treated with abiraterone acetate or docetaxel and comparison with clinical trial outcomes →. Geynisman, DM, Correa, AF, Ramamurthy, C, Beck, JR, Handorf, E. February 2021. Abstract. CAREERS | FLATIRON HEALTH A career at Flatiron is a chance to work with everyone involved in the future of cancer — all under one roof. Researchers, academics, oncologists, engineers and more all work together here to deliver better solutions. This means we have a chance to impact more lives and deliver better outcomes for patients. See open positions.FLATIRON ASSIST™
Flatiron Assist™ captures key data points to speed up prior authorizations and surfaces insights to help practices achieve success in value-based arrangements. The nice thing about Flatiron Assist is that you can get right where you want to go—and get there quickly—without having to dig through an algorithm. OUR TEAM | FLATIRON HEALTH Flatiron is a team of passionate, curious individuals from a wide range of backgrounds, dedicated to improving cancer treatment and accelerating research.PUBLICATIONS
Real-world survival of men with metastatic hormone-sensitive prostate cancer treated with abiraterone acetate or docetaxel and comparison with clinical trial outcomes →. Geynisman, DM, Correa, AF, Ramamurthy, C, Beck, JR, Handorf, E. February 2021. Abstract. REAL-WORLD DATA IN REAL TIME: EARLY LESSONS FROM THE COVID The COVID-19 pandemic is unprecedented in its combination of severity, rapid global spread, and the sheer volume of data needed, generated and analyzed in record time, from scientific studies to social media. OUR TEAM | FLATIRON HEALTH Flatiron is a team of passionate, curious individuals from a wide range of backgrounds, dedicated to improving cancer treatment and accelerating research. FOR COMMUNITY ONCOLOGY OncoEMR® enhances your ability to bring precision medicine to your patient care. OncoTrials® identifies eligible patients so you can help them get access to clinical trials. Flatiron HC™ has been ranked the #1 end-to-end oncology technology solution by Black Book Research. OncoEMR ® is top-rated for overall satisfaction by KLAS’2019
ONCOTRIALS®
OncoTrials can help: Reduce screening volume with eligible patients surfaced at the right time. Identify and track patients with automated flagging of candidate, consented and ineligible patients. Understand and improve research program performance with operational reports. Centrally manage your clinical trial portfolio and output detailed FLATIRON HEALTH ANNOUNCES CLINICAL DECISION SUPPORT Flatiron Health, a healthcare technology company focused on accelerating cancer research and improving patient care, announces the availability of its clinical decision support and pathways application, Flatiron Assistâ„¢, in the App Orchard. Flatiron Assistâ„¢ supports oncologists in selecting therapies in line with best clinical practices, including the National Comprehensive CancerNetwork
OCM MEASURE LIST
OCM MEASURE LIST Version 1.6 . Effective January 1, 2020 . Prepared by: RTI International . 3040 E. Cornwallis Road . Research TrianglePark, NC 27709
FLATIRON RESEARCH SUMMIT In light of this, we have decided to cancel the 2020 Flatiron Research Summit. It is still our goal to promote and share learnings around the use of real-world evidence in oncology. As such, we will be offering a few of the sessions originally planned for the 2020 Flatiron Research Summit via a webinar series starting in October.FLATIRON.COM
flatiron.com
AN INTRO TO REAL-WORLD ENDPOINTS IN ONCOLOGY One key thing to keep in mind when comparing real-world endpoints with trial endpoints is, in the real world, patients come in to see the physician when they don't feel well. Relative to trials, there's this very specific cadence and expectation that we will FLATIRON HEALTHFOR COMMUNITY ONCOLOGYFOR LIFE SCIENCESFOR ACADEMICS & HOSPITALSONCOEMRONCOBILLING Flatiron Health. Dr. James Hamrick & Sarika Vora in their weekly team stand-up. Cancer is smart. Together, we can. be smarter. Accelerating cancer research and improving the quality of care requires the entire industry to work together. Our products connect community oncologists, academics, hospitals, life science researchers and regulators on ABOUT US | FLATIRON HEALTH Our Story. Flatiron Health has come a long way since 2012, when entrepreneurs Nat Turner and Zach Weinberg saw firsthand how a fragmented and siloed healthcare system impacted a family member’s cancer treatment, and set out to gather the best minds in medicine and technology to transform the way cancer is understood and treated. Today, Flatiron continues to lead in U.S. oncology real-worldPUBLICATIONS
Real-world survival of men with metastatic hormone-sensitive prostate cancer treated with abiraterone acetate or docetaxel and comparison with clinical trial outcomes →. Geynisman, DM, Correa, AF, Ramamurthy, C, Beck, JR, Handorf, E. February 2021. Abstract. CAREERS | FLATIRON HEALTH A career at Flatiron is a chance to work with everyone involved in the future of cancer — all under one roof. Researchers, academics, oncologists, engineers and more all work together here to deliver better solutions. This means we have a chance to impact more lives and deliver better outcomes for patients. See open positions.FLATIRON ASSIST™
Flatiron Assist™ captures key data points to speed up prior authorizations and surfaces insights to help practices achieve success in value-based arrangements. The nice thing about Flatiron Assist is that you can get right where you want to go—and get there quickly—without having to dig through an algorithm. OUR TEAM | FLATIRON HEALTH Flatiron is a team of passionate, curious individuals from a wide range of backgrounds, dedicated to improving cancer treatment and accelerating research. FLATIRON HEALTHFOR COMMUNITY ONCOLOGYFOR LIFE SCIENCESFOR ACADEMICS & HOSPITALSONCOEMRONCOBILLING Flatiron Health. Dr. James Hamrick & Sarika Vora in their weekly team stand-up. Cancer is smart. Together, we can. be smarter. Accelerating cancer research and improving the quality of care requires the entire industry to work together. Our products connect community oncologists, academics, hospitals, life science researchers and regulators on ABOUT US | FLATIRON HEALTH Our Story. Flatiron Health has come a long way since 2012, when entrepreneurs Nat Turner and Zach Weinberg saw firsthand how a fragmented and siloed healthcare system impacted a family member’s cancer treatment, and set out to gather the best minds in medicine and technology to transform the way cancer is understood and treated. Today, Flatiron continues to lead in U.S. oncology real-worldPUBLICATIONS
Real-world survival of men with metastatic hormone-sensitive prostate cancer treated with abiraterone acetate or docetaxel and comparison with clinical trial outcomes →. Geynisman, DM, Correa, AF, Ramamurthy, C, Beck, JR, Handorf, E. February 2021. Abstract. CAREERS | FLATIRON HEALTH A career at Flatiron is a chance to work with everyone involved in the future of cancer — all under one roof. Researchers, academics, oncologists, engineers and more all work together here to deliver better solutions. This means we have a chance to impact more lives and deliver better outcomes for patients. See open positions.FLATIRON ASSIST™
Flatiron Assist™ captures key data points to speed up prior authorizations and surfaces insights to help practices achieve success in value-based arrangements. The nice thing about Flatiron Assist is that you can get right where you want to go—and get there quickly—without having to dig through an algorithm. OUR TEAM | FLATIRON HEALTH Flatiron is a team of passionate, curious individuals from a wide range of backgrounds, dedicated to improving cancer treatment and accelerating research.PUBLICATIONS
Real-world survival of men with metastatic hormone-sensitive prostate cancer treated with abiraterone acetate or docetaxel and comparison with clinical trial outcomes →. Geynisman, DM, Correa, AF, Ramamurthy, C, Beck, JR, Handorf, E. February 2021. Abstract. REAL-WORLD DATA IN REAL TIME: EARLY LESSONS FROM THE COVID The COVID-19 pandemic is unprecedented in its combination of severity, rapid global spread, and the sheer volume of data needed, generated and analyzed in record time, from scientific studies to social media. OUR TEAM | FLATIRON HEALTH Flatiron is a team of passionate, curious individuals from a wide range of backgrounds, dedicated to improving cancer treatment and accelerating research. FOR COMMUNITY ONCOLOGY OncoEMR® enhances your ability to bring precision medicine to your patient care. OncoTrials® identifies eligible patients so you can help them get access to clinical trials. Flatiron HC™ has been ranked the #1 end-to-end oncology technology solution by Black Book Research. OncoEMR ® is top-rated for overall satisfaction by KLAS’2019
ONCOTRIALS®
OncoTrials can help: Reduce screening volume with eligible patients surfaced at the right time. Identify and track patients with automated flagging of candidate, consented and ineligible patients. Understand and improve research program performance with operational reports. Centrally manage your clinical trial portfolio and output detailed FLATIRON HEALTH ANNOUNCES CLINICAL DECISION SUPPORT Flatiron Health, a healthcare technology company focused on accelerating cancer research and improving patient care, announces the availability of its clinical decision support and pathways application, Flatiron Assistâ„¢, in the App Orchard. Flatiron Assistâ„¢ supports oncologists in selecting therapies in line with best clinical practices, including the National Comprehensive CancerNetwork
OCM MEASURE LIST
OCM MEASURE LIST Version 1.6 . Effective January 1, 2020 . Prepared by: RTI International . 3040 E. Cornwallis Road . Research TrianglePark, NC 27709
FLATIRON RESEARCH SUMMIT In light of this, we have decided to cancel the 2020 Flatiron Research Summit. It is still our goal to promote and share learnings around the use of real-world evidence in oncology. As such, we will be offering a few of the sessions originally planned for the 2020 Flatiron Research Summit via a webinar series starting in October.FLATIRON.COM
flatiron.com
AN INTRO TO REAL-WORLD ENDPOINTS IN ONCOLOGY One key thing to keep in mind when comparing real-world endpoints with trial endpoints is, in the real world, patients come in to see the physician when they don't feel well. Relative to trials, there's this very specific cadence and expectation that we will arrownextpreviousShapePage 1cardCheck Copy 8Check Copy 8documentemailenvelopeFacebookcopyLinkedInFlatironShapepaperplaysearchTwitterFlatiron
* Technology
* Company
* Publications
* Careers
* Blog
For Community Oncology Flatiron HC™ is the platform for better patient experience, a healthier practice and smarter research.* OncoEMR®
* OncoAirâ„¢
* OncoBilling®
* OncoAnalytics®
* OncoTrials®
* Revenue Cycle Management* Value-Based Care
* Flatiron Assistâ„¢For Life Sciences
Accelerate research with the most advanced real-world evidence platform in oncology. Learn how researchers are applying real-world data.* Partner With Us
For Academics & Hospitals Unlock the promise of your EHR data with Flatiron's enriched datainfrastructure.
Contact us to learn about applications for your cancer center.About Us
Learn more about Flatiron's mission, vision and story.* Our Team
* Our Values
* Blog
Careers
Join the leading tech company in oncology.* Open Positions
* For Engineers
* For Summer InternsResources
Get quick access to information about Flatiron. * Confidentiality Commitments* Press
* Media Kit
* Technology
For Community Oncology* OncoEMR®
* OncoAirâ„¢
* OncoBilling®
* OncoAnalytics®
* OncoTrials®
* Revenue Cycle Management* Value-Based Care
* Flatiron Assistâ„¢For Life Sciences
* Partner With Us
For Academics & Hospitals* Company
About Us
* Our Team
* Our Values
* Blog
Careers
* Open Positions
* For Engineers
* For Summer InternsResources
* Confidentiality Commitments* Press
* Media Kit
* Publications
* Careers
* Blog
Contact Legal & Privacy*
*
*
THE REAL WORLD, IN PRACTICE: Racial and ethnic disparities: What can we learn from RWE? Listen Now. Dr. James Hamrick & Sarika Vora in their weekly team stand-upCANCER IS SMART.
TOGETHER, WE CAN
BE SMARTER.
Accelerating cancer research and improving the quality of care requires the entire industry to work together. Our products connect community oncologists, academics, hospitals, life science researchers and regulators on a shared technology platform. Together, we can learn from the experience of every patient. Dr. Jeremy McDuffie, Tennessee Oncology FOR COMMUNITY ONCOLOGY Flatiron HC™ is more than the leading cancer-specific EHR. It’s the platform for better patient experience, a healthier practice, andsmarter research.
Learn more
The lab at New York Cancer & Blood SpecialistsFOR LIFE SCIENCES
With access to billions of data points on millions of cancer patients treated across our network, Flatiron is changing the way life science companies are using real-world data to accelerate research andgenerate evidence.
Learn more
Shane Woods, Life Sciences Partnerships & Lesley Plotkin, ResearchMarketing
FOR ACADEMICS & HOSPITALS Flatiron’s enriched data infrastructure helps hospitals and academic centers unlock the promise of their EHR data. Researchers and clinicians now have access to research-grade insights from within and beyond the walls of their institution.Learn more
Do well by doing good. Join the leading cancer technology company.Our story
Our values
Join our team
* 1
* 2
* 3
LIFE AT FLATIRON
The talent and dedication of the people working at Flatiron makes everything we do possible. If you’re passionate about having an impact on cancer research and patient care, we’d love to hear fromyou.
Open positions
LET US TELL YOU MORE. We will email you to start the conversation. THANK YOU. WE'LL BE IN TOUCH SHORTLY.Press Release
FLATIRON HEALTH ANNOUNCES RESEARCH TO BE PRESENTED AT AMERICAN SOCIETY OF CLINICAL ONCOLOGY 2021 ANNUAL MEETINGPress Release
LEADING RWD AND ANALYTICS ORGANIZATIONS FORM INDUSTRY COALITION TO ADVANCE POLICIES TO SUPPORT REGULATORY USE OF RWEBlog
FLATIRON HEALTH: THE NEXT CHAPTER BEGINS TODAY* Contact
* Legal & Privacy
Flatiron
*
*
*
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0